Thank you to our Sponsors!
Following the merger of Fujisawa Pharmaceutical and Yamanouchi Pharmaceuticals and ranks in the top 20 global pharmaceutical companies in sales. Fujisawa created the first Japanese pharmaceutical company in Canada by acquiring Lyphomed Canada in the early nineties and becoming Fujisawa Canada. Thanks to Yamanouchi’s rich product pipeline, Astellas Pharma Canada has introduced new products since the merger and looks forward to future growth in several therapeutic categories.
AstraZeneca is a science-led biopharmaceutical company pushing the boundaries of science to deliver life-changing medicines.The company employs roughly 1,200 people in Canada who work to research, develop and market innovative medicines. AstraZeneca Canada was recently designated a global Clinical Hub for oncology and immuno-oncology clinical studies. We are currently leading global oncology clinical studies in lung, head, and neck cancer. The future of treatment for many of today’s diseases lies in uncovering mechanisms that are newly emerging or are still to be discovered. We believe the best way to help patients is to focus on breakthrough science to discover these mechanisms and develop novel, targeted therapies that interact with them. Our focus is on the following core therapy areas: Cardiovascular, Renal and Metabolic diseases (CVRM); Oncology; Rare Disease; Respiratory & Immunology; and Vaccines & Immune Therapies. In 2021, AstraZeneca invested more than $135.6 million in Canadian health sciences research in our core therapy areas.
At Hologic, we live our purpose — to enable healthier lives everywhere, every day — by bringing to life our virtuous circle. Our innovative, life-changing technologies lead to continuous business growth and financial success. These gains allow us to reinvest in programs and initiatives designed to nurture and support women’s health globally. At Hologic, we center our giving efforts in three specific areas to maximize our impact in ways that align with the values of our employees and customers, as well as with what our company holds dear. For us, those areas are: Women’s health, and other healthcare fields in which Hologic operates. Science, technology, engineering and math education (STEM), especially for underprivileged groups. Social and racial equality, especially in healthcare.
For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world — and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities.
Throughout our 125-year history, Roche has grown into one of the world’s largest biotech companies, as well as a leading provider of in-vitro diagnostics and a global supplier of transformative innovative solutions across major disease areas. Our commitment to our people, partners, stakeholders and, most importantly, our patients remains as strong as it was on the first day of our journey.
Diagnexia is your global digital pathology department, an on-call network of expert subspecialty pathologists. The subspecialty pathologists in the Diagnexia network are some of the most widely published and respected names in their fields. They are the authors, lecturers and educators shaping the future of pathology.
Evident supplies advanced solutions that help make the world safer and healthier. Committed to developing new technologies and delivering world-class customer service, our responsibility goes beyond manufacturing products—we are pioneers. We strive to exceed expectations by listening to our customers while anticipating future challenges to offer solutions optimized for your needs. With a rich history, we support our customers with solutions that give them the information they need to do their work, whether it’s researching new medical breakthroughs or inspecting infrastructure to help ensure the safety of society. Through researching and developing advanced technologies, we create leading-edge products used in numerous applications, including clinical and life science research, quality control and assessment, nondestructive testing (NDT), precision measurement and analysis, and environment and natural resources.
FroggaBio is a Canadian Life Science distributor offering the latest in equipment, reagents and consumables to the scientific community. Headquartered in Toronto ON, FroggaBio offers a complete solution for your research needs including everything from basic pipette tips and tubes to the high level capital equipment from well-respected brands in our industry, including: Perkin Elmer, Bioline, Optika, DeNovix, Etaluma, Aurox, Brooks Life Science/4titude, Biological Industries, CAPP, Thomas Scientific and more. FroggaBio also offers a comprehensive OEM line of popular consumables, reagents and small equipment across North America as well as through an international distribution network. In 2019 FroggaBio celebrated its 10 year anniversary, where we continue to promote the strong customer service and product quality standards the company was originally founded on. Whether you work in a lab setting or perform your testing in the field, FroggaBio has the products you need at competitive pricing.
Huron's solutions leverage our 10+ year experience in providing whole slide scanners to leading clinical and research institutions. We pride ourselves on second-to-none image quality, outstanding customer service, and non-standard glass slide and customized, application-specific scanning solutions.We offer an easy-to-use tool for pathologists, researchers and educators to retrieve images that are anatomically similar to the biopsy samples they are reviewing. After highlighting a region of interest, the search engine returns images with similar content along with the corresponding diagnoses. This search capability can be deployed within a single institution or across multiple networks.
KUBTEC, a minority woman-owned company, was founded in Stratford, Connecticut in 2005 and is a progressive research and technology company dedicated to developing 3D tomosynthesis solutions for precision breast cancer margin management. We design world-class innovative, patented, and proprietary 3D specimen imaging and surgical margin management systems for the OR, Pathology Lab, and Biopsy Suite.
Over the past 30 years, Quorum Technologies has established a solid reputation integrating scientific instruments for the Canadian Health Care, Biomedical and Industrial markets. Specializing in Digital Pathology, Microscope and Image Processing, our success is primarily due to our tailored approach to the provision of scientific equipment. In order to provide robust and flexible systems, it is imperative that we thoroughly understand the needs, goals, concerns and future considerations of your lab. Thus, the first step in our approach is an interview with one of our consultants. Based on this discussion we will then design a system ideally suited to those requirements. This includes the provision of all components with competitive pricing, on site installation and customization of the system, comprehensive training as well as advanced technical support and after sales service. It is our goal to provide your organization with the best possible system for your needs and to ensure its continuous value through training, support and service. Quorum innovation Scientists at heart, our developers are continually envisioning ways to improve the technology our customers use to collect and analyze data. Quorum Technologies continues to make technical advances in the areas of live cell imaging, digital pathology and personalized medicine. At Quorum Technologies, we have invested a great deal of time and effort finding the best possible range and balance of products to provide fast, precise and superior results, whatever the application. In the end, this translates to solutions that save you time, improve production, and increase the quality and applicability of your results.
Everything we do is driven by the needs of people who have a rare disease: Our team believes that each person with a rare disease has the right to the best treatment. We have nearly 30 years' experience in bringing orphan drugs to market for rare diseases, with a portfolio of 18 products and a significant research and development program. We help to develop, and work alongside, global networks of patients, patient groups, experts, healthcare professionals, scientists, policy makers and regulators. We employ professionals in over 30 countries, and are rapidly expanding globally. We have unparalleled experience in the development of clinical trials for orphan drugs and in specialist regulatory requirements. Our infrastructure has been developed to uniquely produce, package and distribute very small to high numbers of specialist products worldwide. Recordati Rare Diseases is committed to improving the diagnosis and management of rare diseases through our educational work and the Recordati Rare Diseases Foundation.
Somagen was founded in 1988 in Edmonton, Alberta, remaining faithful over our extensive history, in our commitment to provide patient focused clinical diagnostic solutions to Canadians. Over 30 years later Somagen continues to improve the quality of care for patients, to empower healthcare professionals by providing modern technology for early diagnosis, monitoring of disease, and treatment. Today Somagen specializes in the industry’s most comprehensive in-vitro diagnostic medical devices to include Cellular Pathology, Cancer Monitoring, Assisted Reproductive Technology, Chemistry, Infectious Disease, Hematology and Immunology. Representing suppliers of innovative diagnostic products from around the world, Somagen Diagnostics is a leader in medical device distribution in Canada.Somagen’s Technology and Innovation Team works hand-in-hand with our current and prospective manufacturing partners to provide valued diagnostics tools to healthcare professionals and the patients we collectively serve. We expand on current partnerships, and we forge new relationships, remaining steadfast in our commitment to provide innovative, leading edge, diagnostic technologies that will contribute to the health and wellness of all Canadians.
TECHNIDATA is a major player in the field of software solutions for clinical laboratories and biorepositories. Our solutions serve organizations from the small single-discipline private laboratory to large multi-site and multi-disciplinary state-owned institutions.
As a global market leader Teledyne Lumenera provides an extensive range of high quality digital cameras with unique combinations of speed, resolution and sensitivity to satisfy the demands of today's imaging applications. Teledyne Lumenera also offers custom design services to OEM partners requiring specialized hardware and software features. Our core competencies include digital bus technologies such as USB 3.0, USB 2.0, Ethernet, HDMI and Gigabit Ethernet (GigE) as well as a complete command of digital imaging hardware and software built around CMOS and CCD based imagers. Our diversity provides our customers with the benefits of superior price-to-performance ratios and faster time-to-market. Teledyne Lumenera’s commitment to high quality, cost-effective solutions is unparalleled. Teledyne Lumenera provides customized design services, continuous innovation and licensing options to our partners and OEM customers. Teledyne Lumenera custom cameras can be adapted to fit your application requirements whether simple or complex. Our expertise for timely modifications ranges from small hardware and software adjustments such as private-labelled enclosures, to complete made-to-spec solutions with alternate form-factors and unique mechanicals. Our commitment to innovation and customer service are unparalleled. We recognize that the success of Teledyne Lumenera is highly dependent on our ability to satisfy our customers. Our goal is to provide our external and internal customers with services and experiences that exceed their expectations.
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue of over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD.